No association between OGG1 Ser326Cys polymorphism and breast cancer risk.
Vogel
Ulla
U
National Institute of Occupational Health, DK-2100 Copenhagen, Denmark. ubv@ami.dk
Nexø
Bjørn A
BA
Olsen
Anja
A
Thomsen
Birthe
B
Jacobsen
Nicklas R
NR
Wallin
Håkan
H
Overvad
Kim
K
Tjønneland
Anne
A
D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics*; D016022:Case-Control Studies; D015331:Cohort Studies; D043382:DNA-Formamidopyrimidine Glycosylase; D003718:Denmark; D005260:Female; D005500:Follow-Up Studies; D005787:Gene Frequency / Q000235:genetics; D008040:Genetic Linkage / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000453:epidemiology / Q000235:genetics; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D009699:N-Glycosyl Hydrolases / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D017698:Postmenopause / Q000235:genetics; D011446:Prospective Studies; D012307:Risk Factors; D013223:Statistics as Topic; D016387:Women's Health
D005819:Genetic Markers; D009699:N-Glycosyl Hydrolases; D043382:DNA-Formamidopyrimidine Glycosylase